Every Saturday, Jesse Staniforth’s WeedWeek Canada newsletter serves up a peerless rundown on what’s happening in the world’s largest fully-legal cannabis industry.
This week’s newsletter is essential for everyone in the pot business. It is surely the best account anywhere of how the Canadian industry has responded to the Covid-19 crisis. As with so much of what happens in Canada, it’s familiar to American eyes, and yet ineffably different.
A few highlights:
- Ottawa may shut the industry out of the nationwide stimulus it is preparing.
- The virus has exacerbated tensions between MED activists and the REC-oriented industry.
- Even in the face of a global pandemic, Canada’s semi-professional weed critics are still super mean (and funny).
- (A Guardian piece also highlighted the poor quality of Canada’s legal pot.)
The Canada newsletter also has a good run-down on a big non-virus related story.
- MarketWatch broke news that the U.S. Securities and Exchange Commission told Canadian producer Cronos Group, to retain records related to how it recognizes certain revenue.
- Cronos, which has received an investment from Marlboro parent company Altria and trades on the NASDAQ, declined to comment.
- The company has ties to the investment firm Gotham Green Partners.
Read this week’s issue of WeedWeek Canada.
